Sai Life Sciences Share Price
1589.10+14.30 (+0.91%)
+87.43% past 1 Year
Sai Life Sciences is a fully integrated, science-led contract research, development, and manufacturing organization (CRDMO) focused on small molecule new chemical entities (NCEs). It serves global pharmaceutical and biotechnology companies
Corporate filings & documents
Announcements
Allotment of 80 600 Equity shares having Face Value ?1/- each as per Companys ESOP Plans
2 days agoAllotment of 80 600 Equity shares having Face Value ?1/- each as per Companys ESOP Plans
2 days agoNewspaper Publication relating to 27th AGM (Post-dispatch Advt.)
1 week agoNewspaper Publication relating to 27th AGM (Post-dispatch Advt.)
1 week agoPlease refer the attachment
1 week agoPlease refer the attachment
1 week agoBusiness Responsibility and Sustainability Report (BRSR) and ESG Databook of Sai Life Sciences Limited for the FY 2025-26
1 week agoBusiness Responsibility and Sustainability Report (BRSR) and ESG Databook of Sai Life Sciences Limited for the FY 2025-26
1 week agoIntegrated Annual Report of Sai Life Sciences Limited for the FY 2025-26
1 week agoIntegrated Annual Report of Sai Life Sciences Limited for the FY 2025-26
1 week agoNotice of 27th Annual General Meeting (AGM) of the Company
1 week agoNotice of 27th Annual General Meeting (AGM) of the Company
1 week agoNewspaper Publication relating to 27th AGM (Pre-dispatch Advt.)
1 week agoNewspaper Publication relating to 27th AGM (Pre-dispatch Advt.)
1 week agoInformation relating to 27th Annual General Meeting (AGM) and Cut-off date for e-voting.
1 week agoInformation relating to 27th Annual General Meeting (AGM) and Cut-off date for e-voting.
1 week agoTranscript of Earnings Conference Call organised on 07 August 2026
3 weeks agoTranscript of Earnings Conference Call organised on 07 August 2026
3 weeks agoNewspaper publication for Un-audited Financial Results of the Company for the quarter ended on 30 June 2026
3 weeks agoNewspaper publication for Un-audited Financial Results of the Company for the quarter ended on 30 June 2026
3 weeks agoMonitoring Agency Report for the Quarter ended on 30 June 2026
3 weeks agoRecording of Earnings Call for the Unaudited Financial Results of the Company for the quarter ended on 30 June 2026.
3 weeks agoRecording of Earnings Call for the Unaudited Financial Results of the Company for the quarter ended on 30 June 2026.
3 weeks agoInvestor Presentation for the quarter ended on 30 June 2026
4 weeks agoInvestor Presentation for the quarter ended on 30 June 2026
4 weeks agoAllotment of 18 700 equity shares under Employee Stock Option Plan
4 weeks agoPress Release for the Unaudited financial results for the quarter ended 30 June 2026
4 weeks agoUnaudited Financial results (Standalone and Consolidate) for the Quarter ended on 30 June 2026
4 weeks agoUnaudited Financial results (Standalone and Consolidate) for the Quarter ended on 30 June 2026
4 weeks agoBoard Meeting Outcome for Approval of Unaudited Financial Results (Standalone and Consolidated) For the Quarter Ended On 30 June 2026
4 weeks agoBoard Meeting Outcome for Approval of Unaudited Financial Results (Standalone and Consolidated) For the Quarter Ended On 30 June 2026
4 weeks agoAnalyst/Investor Meet on 13 August 2026 and 14 August 2026 at Singapore
1 month agoAnalyst/Investor Meet on 13 August 2026 and 14 August 2026 at Singapore
1 month agoEarnings Conference call Invite to discuss Un-audited Financial Results of the Company for the Quarter ended 30 June 2026.
1 month agoEarnings Conference call Invite to discuss Un-audited Financial Results of the Company for the Quarter ended 30 June 2026.
1 month agoAllotment of 8 900 Equity Shares under ESOP 2008 Scheme of the Company
1 month agoAllotment of 8 900 Equity Shares under ESOP 2008 Scheme of the Company
1 month agoPlease refer to enclosed Intimation
1 month agoPlease refer to enclosed Intimation
1 month agoSai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2026
2 months agoSai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2026
2 months agoTrading Window Closure Intimation
2 months agoTrading Window Closure Intimation
2 months agoAllotment of 1 70 501 Equity Shares under ESOP schemes of the Company.
2 months agoAllotment of 1 70 501 Equity Shares under ESOP schemes of the Company.
2 months agoAnalyst/Investor Meet on 11 June 2026 at Hyderabad
2 months agoAnalyst/Investor Meet on 11 June 2026 at Hyderabad
2 months agoIntimation of schedule of meeting with analyst / Investor on 3rd and 4th June 2026 at Mumbai.
3 months agoIntimation of schedule of meeting with analyst / Investor on 3rd and 4th June 2026 at Mumbai.
3 months agoTranscript of Earnings Call for the Audited Financial Results for the quarter and year ended 31 March 2026.
3 months agoConcalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Plot No. D S-7, I K P Knowledge Park Turkapally Village, Shameerpet Mandal Medchal- Malkajgiri District Hyderabad Telangana PIN: 500078 Tel No: 040-68156000 Fax No: 040-23542666 Email: [email protected] Internet: www.sailife.com
Registrars
PIN: Tel No: Fax No: Email:
Management
Runa Karan, Company Secretary & Compliance Officer
Ranga Raju Kanumuri, Chairman
Krishnam Raju Kanumuri, Managing Director & Chief Executive Officer
Sivaramakrishnan Chittor, Whole Time Director & CFO
Suchita Sharma, Non Executive Independent Director
Ramesh Ganesh Iyer, Non Executive Independent Director
Dinesh V Patel, Non Executive Independent Director
Details
BSE 544306
NSE SAILIFE
ISIN INE570L01029